Global Aortic Stent Grafts Market Size By Type (Endovascular Aneurysm Repair (EVAR), Abdominal Aortic Aneurysm Repair), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2...

The Global Aortic Stent Grafts Market was valued at USD 3.9 billion in 2023 and is projected to surpass USD 7.1 billion by 2031, growing at a CAGR of 7.8% during the forecast period of 2023–2031. The growth is attributed to the increasing prevalence of aortic aneurysms, the growing aging population, advancements in stent graft design, and the shift towards minimally invasive surgical procedures. Aortic stent grafts are used primarily in endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), procedures that are gaining significant traction globally due to their reduced recovery time, minimal postoperative complications, and rising patient preference.

Drivers:

Rising Incidence of Aortic Aneurysms

The increasing number of patients diagnosed with abdominal and thoracic aortic aneurysms is a primary driver. Factors such as hypertension, smoking, and genetic predispositions have contributed to the rising prevalence, subsequently fueling demand for stent graft systems.

Technological Advancements in Stent Graft Design

Innovations such as fenestrated and branched stent grafts are improving procedural outcomes for complex anatomies. These advancements enable personalized treatments, expand the patient pool eligible for EVAR/TEVAR, and enhance long-term device performance.

Preference for Minimally Invasive Surgeries

Growing patient and physician preference for minimally invasive procedures over open surgical repair is accelerating the adoption of aortic stent grafts. Reduced hospitalization, quicker recovery, and fewer complications are contributing to market penetration.

Restraints:

High Costs and Reimbursement Challenges

The high cost of aortic stent grafts and associated procedures limits accessibility, particularly in low- and middle-income countries. Additionally, inconsistent reimbursement policies across regions pose a hurdle for market expansion.

Risk of Endoleaks and Postoperative Complications

Despite clinical success, the risk of complications such as endoleaks, stent migration, and graft failure can impact long-term outcomes and restrict physician adoption in complex cases.

Opportunity:

Expanding Geriatric Population Base

With aging being a key risk factor for aortic aneurysms, the increasing global geriatric population presents a significant growth opportunity for market players, particularly in developed nations with advanced healthcare systems.

Emerging Markets and Healthcare Infrastructure Development

Rapid development of healthcare infrastructure in Asia-Pacific, Latin America, and parts of Africa is creating untapped opportunities. Governments are investing in advanced surgical capabilities and training to cater to complex vascular procedures.

Market by System Type Insights:

The market is segmented into Abdominal Aortic Stent Grafts and Thoracic Aortic Stent Grafts. In 2023, Abdominal Aortic Stent Grafts held the largest market share due to the higher prevalence of abdominal aortic aneurysms (AAA). However, Thoracic Aortic Stent Grafts are projected to witness faster growth, driven by increased recognition and screening of thoracic aneurysms and improved outcomes from TEVAR procedures.

Market by End-use Insights:

Based on end-use, Hospitals and Surgical Centers emerged as the dominant segment in 2023, accounting for over 60% of the market. These settings are equipped with advanced imaging and surgical facilities essential for EVAR and TEVAR procedures. The Ambulatory Surgical Centers (ASCs) segment is expected to grow significantly, supported by healthcare decentralization and increasing adoption of outpatient vascular procedures.

Market by Regional Insights:

North America led the market in 2023 due to the high prevalence of aortic aneurysms, early adoption of advanced medical technologies, favorable reimbursement systems, and the presence of major market players. Europe followed closely, driven by increased public awareness and organized screening programs. Meanwhile, Asia-Pacific is expected to grow at the fastest pace, fueled by healthcare infrastructure expansion, improving diagnosis rates, and rising elderly population.

Competitive Scenario:

Key players in the Global Aortic Stent Grafts Market include Medtronic plc, Cook Medical, Gore Medical (W. L. Gore & Associates), Terumo Corporation, Endologix LLC, Lombard Medical, Cardinal Health, Inc., and MicroPort Scientific Corporation. These companies focus on product innovation, clinical trials, and strategic acquisitions to strengthen their market presence.

Key Developments:

2023: Medtronic launched a next-generation thoracic stent graft system with enhanced conformability and navigation.

2024: Gore Medical received FDA approval for its new branched endograft for complex aortic arch aneurysms.

2025: Cook Medical expanded its manufacturing capabilities in Asia-Pacific to meet growing regional demand.

Scope of Work – Global Aortic Stent Grafts Market

Report Metric Details

Market Size (2023) USD 3.9 billion

Projected Market Size (2031) USD 7.1 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (Abdominal, Thoracic); By End-Use; Region

Growth Drivers Increasing aneurysm prevalence, innovation in stent grafts

Opportunities Aging population, emerging market expansion

FAQs:

1) What is the current market size of the Global Aortic Stent Grafts Market?

The market was valued at USD 3.9 billion in 2023.

2) What is the major growth driver of the Global Aortic Stent Grafts Market?

The major growth driver is the rising incidence of aortic aneurysms and increased adoption of minimally invasive procedures.

3) Which is the largest region during the forecast period in the Global Aortic Stent Grafts Market?

North America is the largest region, driven by high disease prevalence and advanced healthcare systems.

4) Which segment accounted for the largest market share in the Global Aortic Stent Grafts Market?

The Abdominal Aortic Stent